800-872-2273

Clinical Trials and Studies

Your participation matters. Help us discover and cure!

Contact us at (800) USC-CARE (800-872-2273)

Study Title Principal Investigator
VNS Therapy for Treatment-Resistant Depression
The purpose of this study is to track active VNS Therapy treatment in subjects with Treatment-Resistant Depression (TRD) and to better understand the reduction in the severity of baseline TRD symptoms. Data will be collected on your responses to study treatments, quality of life, productivity, and your use of healthcare services. Your participation in this study will consist of evaluations by the study doctor (or his/her designee), who will review your past and current medical and psychiatric history, and several questionnaires which you will complete during several follow-up visits over time. 
Recruiting | treatment resistant depression | Not Multisite
Ashraf Elmashat
A pilot study of safety and efficacy of spectroscopic diagnosis of pancreatic lesions (Spy Panc)
The objective of this study is to determine if a minimally invasive optical probe can accurately predict a histological diagnosis of dysplastic or malignant tumor cells in solid lesions of the pancreas. If effective, this optical probe would facilitate the detection of malignant and pre-malignant pancreatic lesions. This would lead to more accurate decision-making as to which patients require surgical resection versus patients who should be spared from major surgery.
Not yet recruiting | pancreas | Multisite
Ari Padilla
View Research Profile
Tirzepatide Alcohol Outcomes Study (TAOS)
This clinical trial is investigating the effects of a GLP-1-based medication, tirzepatide, on alcohol-related outcomes in adults seeking to reduce or quit drinking.
Recruiting | Alcohol | Not Multisite
Christian Hendershot, PhD
Powered by SC CTSI